KURA – Kura Oncology, Inc.
KURA — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
16.79
Margin Of Safety %
Put/Call OI Ratio
0.31
EPS Next Q Diff
-0.03
EPS Last/This Y
-0.17
EPS This/Next Y
0.91
Price
8.82
Target Price
31.91
Analyst Recom
1.21
Performance Q
-7.55
Upside
-1,361.9%
Beta
0.27
Ticker: KURA
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | KURA | 9.39 | 0.54 | 0.02 | 16309 |
| 2026-03-10 | KURA | 9.27 | 0.53 | 0.06 | 16545 |
| 2026-03-11 | KURA | 9.21 | 0.52 | 0.06 | 16764 |
| 2026-03-12 | KURA | 8.84 | 0.52 | 1.88 | 16893 |
| 2026-03-13 | KURA | 8.84 | 0.52 | 0.45 | 16893 |
| 2026-03-17 | KURA | 8.59 | 0.50 | 0.00 | 17227 |
| 2026-03-18 | KURA | 8.4 | 0.50 | 0.00 | 17235 |
| 2026-03-19 | KURA | 8.42 | 0.50 | 0.05 | 17191 |
| 2026-03-20 | KURA | 8.26 | 0.50 | 0.10 | 17244 |
| 2026-03-23 | KURA | 8.31 | 0.27 | 0.11 | 10884 |
| 2026-03-24 | KURA | 8.08 | 0.26 | 0.03 | 11227 |
| 2026-03-25 | KURA | 8.55 | 0.26 | 0.02 | 11613 |
| 2026-03-26 | KURA | 8.38 | 0.25 | 0.00 | 11839 |
| 2026-03-27 | KURA | 7.75 | 0.25 | 15.17 | 11880 |
| 2026-03-30 | KURA | 7.72 | 0.31 | 0.48 | 12386 |
| 2026-03-31 | KURA | 8.11 | 0.32 | 0.52 | 12532 |
| 2026-04-01 | KURA | 8.32 | 0.32 | 0.25 | 12748 |
| 2026-04-02 | KURA | 8.61 | 0.32 | 0.04 | 12742 |
| 2026-04-06 | KURA | 8.51 | 0.31 | 0.07 | 13218 |
| 2026-04-07 | KURA | 8.83 | 0.31 | 0.00 | 13170 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | KURA | 9.38 | -41.9 | -170.7 | -3.27 |
| 2026-03-10 | KURA | 9.26 | -41.9 | -109.8 | -3.27 |
| 2026-03-11 | KURA | 9.22 | -41.9 | -114.8 | -3.27 |
| 2026-03-12 | KURA | 8.84 | -41.9 | -80.4 | -3.27 |
| 2026-03-13 | KURA | 8.65 | -11.5 | -342.7 | -3.27 |
| 2026-03-17 | KURA | 8.58 | -11.5 | -23.6 | -3.27 |
| 2026-03-18 | KURA | 8.40 | -11.5 | -9.3 | -3.27 |
| 2026-03-19 | KURA | 8.42 | -11.5 | -47.6 | -3.27 |
| 2026-03-20 | KURA | 8.26 | -11.5 | 3.9 | -3.27 |
| 2026-03-23 | KURA | 8.31 | -11.5 | -62.7 | -3.27 |
| 2026-03-24 | KURA | 8.07 | -11.5 | 36.1 | -3.27 |
| 2026-03-25 | KURA | 8.55 | -11.5 | -250.9 | -3.27 |
| 2026-03-26 | KURA | 8.38 | -11.5 | -2.0 | -3.27 |
| 2026-03-27 | KURA | 7.74 | -11.5 | 146.3 | -3.27 |
| 2026-03-30 | KURA | 7.72 | -11.5 | -31.7 | -3.27 |
| 2026-03-31 | KURA | 8.11 | -11.5 | -359.9 | -3.27 |
| 2026-04-01 | KURA | 8.32 | -11.5 | -123.4 | -3.27 |
| 2026-04-02 | KURA | 8.62 | -11.5 | -133.7 | -3.27 |
| 2026-04-06 | KURA | 8.51 | -12.1 | -20.7 | -3.35 |
| 2026-04-07 | KURA | 8.82 | -12.1 | -125.2 | -3.35 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | KURA | -4.99 | 0.96 | 16.40 |
| 2026-03-10 | KURA | -6.63 | 0.96 | 16.40 |
| 2026-03-11 | KURA | -6.63 | 0.96 | 17.03 |
| 2026-03-12 | KURA | -6.63 | 0.96 | 17.03 |
| 2026-03-13 | KURA | -6.63 | 0.96 | 17.03 |
| 2026-03-17 | KURA | -6.63 | 0.94 | 17.03 |
| 2026-03-18 | KURA | -6.63 | 0.94 | 17.03 |
| 2026-03-19 | KURA | -6.63 | 0.94 | 17.03 |
| 2026-03-20 | KURA | -6.63 | 0.94 | 17.03 |
| 2026-03-23 | KURA | -6.63 | 0.94 | 17.03 |
| 2026-03-24 | KURA | -6.63 | 0.94 | 17.03 |
| 2026-03-25 | KURA | -6.63 | 0.94 | 16.79 |
| 2026-03-26 | KURA | -6.63 | 0.94 | 16.79 |
| 2026-03-27 | KURA | -6.63 | 0.94 | 16.79 |
| 2026-03-30 | KURA | -4.05 | 0.93 | 16.79 |
| 2026-03-31 | KURA | -4.05 | 0.93 | 16.79 |
| 2026-04-01 | KURA | -4.05 | 0.93 | 16.79 |
| 2026-04-02 | KURA | -4.05 | 0.93 | 16.79 |
| 2026-04-06 | KURA | -4.05 | 0.91 | 16.79 |
| 2026-04-07 | KURA | -4.05 | 0.91 | 16.79 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.92
Avg. EPS Est. Current Quarter
-0.74
Avg. EPS Est. Next Quarter
-0.95
Insider Transactions
-4.05
Institutional Transactions
0.91
Beta
0.27
Average Sales Estimate Current Quarter
26
Average Sales Estimate Next Quarter
18
Fair Value
Quality Score
40
Growth Score
26
Sentiment Score
91
Actual DrawDown %
70.9
Max Drawdown 5-Year %
-81.5
Target Price
31.91
P/E
Forward P/E
PEG
P/S
11.55
P/B
4.45
P/Free Cash Flow
EPS
-3.18
Average EPS Est. Cur. Y
-3.35
EPS Next Y. (Est.)
-2.44
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-412.95
Relative Volume
0.97
Return on Equity vs Sector %
-187.5
Return on Equity vs Industry %
-170.9
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.29
EBIT Estimation
-125.2
◆
KURA
Healthcare
$8.82
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
56.2
Range 1M
57.9%
Sup Dist
5.1%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-10.7%
EPS NY
26.5%
52W%
46.6%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+261.8% upside
Upside
+261.8%
Quality
40
Kura Oncology, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 260
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
KURA
Latest News
—
Caricamento notizie per KURA…
stock quote shares KURA – Kura Oncology, Inc. Stock Price stock today
news today KURA – Kura Oncology, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch KURA – Kura Oncology, Inc. yahoo finance google finance
stock history KURA – Kura Oncology, Inc. invest stock market
stock prices KURA premarket after hours
ticker KURA fair value insiders trading